Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1993 Jul 1;293(Pt 1):243–247. doi: 10.1042/bj2930243

Dystrophin is phosphorylated by endogenous protein kinases.

M Luise 1, C Presotto 1, L Senter 1, R Betto 1, S Ceoldo 1, S Furlan 1, S Salvatori 1, R A Sabbadini 1, G Salviati 1
PMCID: PMC1134346  PMID: 8392335

Abstract

Dystrophin, the protein coded by the gene missing in Duchenne muscular dystrophy, is assumed to be a component of the membrane cytoskeleton of skeletal muscle. Like other cytoskeletal proteins in different cell types, dystrophin bound to sarcolemma membranes was found to be phosphorylated by endogenous protein kinases. The phosphorylation of dystrophin was activated by cyclic AMP, cyclic GMP, calcium and calmodulin, and was inhibited by cyclic AMP-dependent protein kinase peptide inhibitor, mastoparan and heparin. These results suggest that membrane-bound dystrophin is a substrate of endogenous cyclic AMP- and cyclic GMP-dependent protein kinases, calcium/calmodulin-dependent kinase and casein kinase II. The possibility that dystrophin could be phosphorylated by protein kinase C is suggested by the inhibition of phosphorylation by staurosporin. On the other hand dystrophin seems not to be a substrate for protein tyrosine kinases, as shown by the lack of reaction of phosphorylated dystrophin with a monoclonal antiphosphotyrosine antibody. Sequence analysis indicates that dystrophin contains seven potential phosphorylation sites for cyclic AMP- and cyclic GMP-dependent protein kinases (all localized in the central rod domain of the molecule) as well as several sites for protein kinase C and casein kinase II. Interestingly, potential sites of phosphorylation by protein kinase C and casein kinase II are located in the proximity of the actin-binding site. These results suggest, by analogy with what has been demonstrated in the case of other cytoskeletal proteins, that the phosphorylation of dystrophin by endogenous protein kinases may modulate both self assembly and interaction of dystrophin with other cytoskeletal proteins in vivo.

Full text

PDF
243

Images in this article

245Figure 1
on p.245
246Figure 2
on p.246
246Figure 3
on p.246

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arahata K., Ishiura S., Ishiguro T., Tsukahara T., Suhara Y., Eguchi C., Ishihara T., Nonaka I., Ozawa E., Sugita H. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchenne muscular dystrophy peptide. Nature. 1988 Jun 30;333(6176):861–863. doi: 10.1038/333861a0. [DOI] [PubMed] [Google Scholar]
  2. Barnea E., Zuk D., Simantov R., Nudel U., Yaffe D. Specificity of expression of the muscle and brain dystrophin gene promoters in muscle and brain cells. Neuron. 1990 Dec;5(6):881–888. doi: 10.1016/0896-6273(90)90348-j. [DOI] [PubMed] [Google Scholar]
  3. Bennett V. Spectrin-based membrane skeleton: a multipotential adaptor between plasma membrane and cytoplasm. Physiol Rev. 1990 Oct;70(4):1029–1065. doi: 10.1152/physrev.1990.70.4.1029. [DOI] [PubMed] [Google Scholar]
  4. Bonilla E., Samitt C. E., Miranda A. F., Hays A. P., Salviati G., DiMauro S., Kunkel L. M., Hoffman E. P., Rowland L. P. Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell. 1988 Aug 12;54(4):447–452. doi: 10.1016/0092-8674(88)90065-7. [DOI] [PubMed] [Google Scholar]
  5. Bornemann A., Schmalbruch H. Antidystrophin stains triadic junctions in regenerating rat muscles. Muscle Nerve. 1991 Dec;14(12):1177–1181. doi: 10.1002/mus.880141206. [DOI] [PubMed] [Google Scholar]
  6. Brenner S. L., Korn E. D. Spectrin-actin interaction. Phosphorylated and dephosphorylated spectrin tetramer cross-link F-actin. J Biol Chem. 1979 Sep 10;254(17):8620–8627. [PubMed] [Google Scholar]
  7. Campbell K. P., Kahl S. D. Association of dystrophin and an integral membrane glycoprotein. Nature. 1989 Mar 16;338(6212):259–262. doi: 10.1038/338259a0. [DOI] [PubMed] [Google Scholar]
  8. Chang H. W., Bock E., Bonilla E. Dystrophin in electric organ of Torpedo californica homologous to that in human muscle. J Biol Chem. 1989 Dec 15;264(35):20831–20834. [PubMed] [Google Scholar]
  9. Cheng H. C., Kemp B. E., Pearson R. B., Smith A. J., Misconi L., Van Patten S. M., Walsh D. A. A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem. 1986 Jan 25;261(3):989–992. [PubMed] [Google Scholar]
  10. Cullen M. J., Walsh J., Nicholson L. V., Harris J. B., Zubrzycka-Gaarn E. E., Ray P. N., Worton R. G. Immunogold labelling of dystrophin in human muscle, using an antibody to the last 17 amino acids of the C-terminus. Neuromuscul Disord. 1991;1(2):113–119. doi: 10.1016/0960-8966(91)90058-z. [DOI] [PubMed] [Google Scholar]
  11. Ervasti J. M., Campbell K. P. Membrane organization of the dystrophin-glycoprotein complex. Cell. 1991 Sep 20;66(6):1121–1131. doi: 10.1016/0092-8674(91)90035-w. [DOI] [PubMed] [Google Scholar]
  12. Feener C. A., Koenig M., Kunkel L. M. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature. 1989 Apr 6;338(6215):509–511. doi: 10.1038/338509a0. [DOI] [PubMed] [Google Scholar]
  13. Harris H. W., Jr, Lux S. E. Structural characterization of the phosphorylation sites of human erythrocyte spectrin. J Biol Chem. 1980 Dec 10;255(23):11512–11520. [PubMed] [Google Scholar]
  14. Hoffman E. P., Brown R. H., Jr, Kunkel L. M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell. 1987 Dec 24;51(6):919–928. doi: 10.1016/0092-8674(87)90579-4. [DOI] [PubMed] [Google Scholar]
  15. Hoffman E. P., Kunkel L. M. Dystrophin abnormalities in Duchenne/Becker muscular dystrophy. Neuron. 1989 Jan;2(1):1019–1029. doi: 10.1016/0896-6273(89)90226-2. [DOI] [PubMed] [Google Scholar]
  16. Jones L. R. Rapid preparation of canine cardiac sarcolemmal vesicles by sucrose flotation. Methods Enzymol. 1988;157:85–91. doi: 10.1016/0076-6879(88)57070-2. [DOI] [PubMed] [Google Scholar]
  17. Knudson C. M., Hoffman E. P., Kahl S. D., Kunkel L. M., Campbell K. P. Evidence for the association of dystrophin with the transverse tubular system in skeletal muscle. J Biol Chem. 1988 Jun 15;263(17):8480–8484. [PubMed] [Google Scholar]
  18. Koenig M., Monaco A. P., Kunkel L. M. The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell. 1988 Apr 22;53(2):219–228. doi: 10.1016/0092-8674(88)90383-2. [DOI] [PubMed] [Google Scholar]
  19. Lederfein D., Levy Z., Augier N., Mornet D., Morris G., Fuchs O., Yaffe D., Nudel U. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5346–5350. doi: 10.1073/pnas.89.12.5346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Levine B. A., Moir A. J., Patchell V. B., Perry S. V. The interaction of actin with dystrophin. FEBS Lett. 1990 Apr 9;263(1):159–162. doi: 10.1016/0014-5793(90)80728-2. [DOI] [PubMed] [Google Scholar]
  21. Lu P. W., Tao M. Phosphorylation of protein tyrosine by human erythrocyte casein kinase A. Biochem Biophys Res Commun. 1986 Sep 30;139(3):855–860. doi: 10.1016/s0006-291x(86)80256-x. [DOI] [PubMed] [Google Scholar]
  22. Malencik D. A., Anderson S. R. High affinity binding of the mastoparans by calmodulin. Biochem Biophys Res Commun. 1983 Jul 18;114(1):50–56. doi: 10.1016/0006-291x(83)91592-9. [DOI] [PubMed] [Google Scholar]
  23. Mitchell R. D., Palade P., Fleischer S. Purification of morphologically intact triad structures from skeletal muscle. J Cell Biol. 1983 Apr;96(4):1008–1016. doi: 10.1083/jcb.96.4.1008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ohlendieck K., Campbell K. P. Dystrophin constitutes 5% of membrane cytoskeleton in skeletal muscle. FEBS Lett. 1991 Jun 3;283(2):230–234. doi: 10.1016/0014-5793(91)80595-t. [DOI] [PubMed] [Google Scholar]
  25. Ohlendieck K., Ervasti J. M., Snook J. B., Campbell K. P. Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J Cell Biol. 1991 Jan;112(1):135–148. doi: 10.1083/jcb.112.1.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pons F., Augier N., Heilig R., Léger J., Mornet D., Léger J. J. Isolated dystrophin molecules as seen by electron microscopy. Proc Natl Acad Sci U S A. 1990 Oct;87(20):7851–7855. doi: 10.1073/pnas.87.20.7851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Rapaport D., Lederfein D., den Dunnen J. T., Grootscholten P. M., Van Ommen G. J., Fuchs O., Nudel U., Yaffe D. Characterization and cell type distribution of a novel, major transcript of the Duchenne muscular dystrophy gene. Differentiation. 1992 Apr;49(3):187–193. doi: 10.1111/j.1432-0436.1992.tb00666.x. [DOI] [PubMed] [Google Scholar]
  28. Salvatori S., Damiani E., Barhanin J., Furlan S., Salviati G., Margreth A. Co-localization of the dihydropyridine receptor and the cyclic AMP-binding subunit of an intrinsic protein kinase to the junctional membrane of the transverse tubules of skeletal muscle. Biochem J. 1990 May 1;267(3):679–687. doi: 10.1042/bj2670679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Salviati G., Betto R., Ceoldo S., Biasia E., Bonilla E., Miranda A. F., Dimauro S. Cell fractionation studies indicate that dystrophin is a protein of surface membranes of skeletal muscle. Biochem J. 1989 Mar 15;258(3):837–841. doi: 10.1042/bj2580837. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Tamaoki T., Nomoto H., Takahashi I., Kato Y., Morimoto M., Tomita F. Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase. Biochem Biophys Res Commun. 1986 Mar 13;135(2):397–402. doi: 10.1016/0006-291x(86)90008-2. [DOI] [PubMed] [Google Scholar]
  31. Tuazon P. T., Traugh J. A. Casein kinase I and II--multipotential serine protein kinases: structure, function, and regulation. Adv Second Messenger Phosphoprotein Res. 1991;23:123–164. [PubMed] [Google Scholar]
  32. Ungewickell E., Gratzer W. Self-association of human spectrin. A thermodynamic and kinetic study. Eur J Biochem. 1978 Aug 1;88(2):379–385. doi: 10.1111/j.1432-1033.1978.tb12459.x. [DOI] [PubMed] [Google Scholar]
  33. Wakayama Y., Shibuya S. Gold-labelled dystrophin molecule in muscle plasmalemma of mdx control mice as seen by electron microscopy of deep etching replica. Acta Neuropathol. 1991;82(3):178–184. doi: 10.1007/BF00294443. [DOI] [PubMed] [Google Scholar]
  34. Watkins S. C., Hoffman E. P., Slayter H. S., Kunkel L. M. Immunoelectron microscopic localization of dystrophin in myofibres. Nature. 1988 Jun 30;333(6176):863–866. doi: 10.1038/333863a0. [DOI] [PubMed] [Google Scholar]
  35. Way M., Pope B., Cross R. A., Kendrick-Jones J., Weeds A. G. Expression of the N-terminal domain of dystrophin in E. coli and demonstration of binding to F-actin. FEBS Lett. 1992 Apr 27;301(3):243–245. doi: 10.1016/0014-5793(92)80249-g. [DOI] [PubMed] [Google Scholar]
  36. Yarom R., Morris G. E., Froede R., Schaper J. Myocardial dystrophin immunolocalization at sarcolemma and transverse tubules. Experientia. 1992 Jun 15;48(6):614–616. doi: 10.1007/BF01920250. [DOI] [PubMed] [Google Scholar]
  37. Yuan S., Sen A. K. Characterization of the membrane-bound protein kinase C and its substrate proteins in canine cardiac sarcolemma. Biochim Biophys Acta. 1986 Apr 8;886(1):152–161. doi: 10.1016/0167-4889(86)90221-1. [DOI] [PubMed] [Google Scholar]
  38. Zubrzycka-Gaarn E. E., Bulman D. E., Karpati G., Burghes A. H., Belfall B., Klamut H. J., Talbot J., Hodges R. S., Ray P. N., Worton R. G. The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature. 1988 Jun 2;333(6172):466–469. doi: 10.1038/333466a0. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES